Phase 1 N=12 Prevention

Safety Evaluation of Advantage Anti-Caries Varnish

Dental Caries

Bottom Line

View on ClinicalTrials.gov: NCT02645617 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jan 2020

Primary outcome: Primary: Soft Tissue — 0 Participants

Study Design & Population

Study type: Interventional
Phase: Phase 1
Interventions: Varnish (Drug)
Age: Pediatric · 0+ yrs
Sex: All
Sponsor: Advantage Dental Services, LLC
Primary completion: Sep 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Soft Tissue	—	—
SECONDARY Adverse Events	—	—

Summary

The purpose of the study is to confirm the safety of Advantage Anti-Caries Varnish.

Eligibility Criteria

Inclusion Criteria

Healthy

Exclusion Criteria

Weight less than 15 kg or hypersensitivity to iodine

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02645617). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.